End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.
about
Fabry disease in latin america: data from the fabry registry.Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry.The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry.Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease.Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease.Fabry disease: the many faces of a single disorder.Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation.Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies.Fabry cardiomyopathy.Fabry's Disease: Case Series and Review of LiteratureFibrosis: a key feature of Fabry disease with potential therapeutic implicationsRenal complications of Fabry disease in childrenAltered dynamics of a lipid raft associated protein in a kidney model of Fabry diseaseEffects of enzyme replacement therapy in Fabry disease--a comprehensive review of the medical literature.Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages.Designing drugs that combat kidney damage.Is it or is it not a pathogenic mutation? Is it or is it not the podocyte?Cardiac device-related endocarditis in the patient with end-stage renal failure in the course of Fabry disease.Fabry disease in Argentina: an evaluation of patients enrolled in the Fabry Registry.Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study.Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy.Fabry disease
P2860
Q30592389-BC2B3CC9-9D4F-4951-B8AA-D23B96D97DCAQ30632134-57FA94A8-44A3-42E3-AC06-0AA4D8694A5CQ30874048-B33E19B2-A1A2-4FFA-8AF1-29A01C18BBFBQ31060724-70E6CAD7-25F1-47F5-95C2-D0683EF71191Q33645550-9277062E-2897-432D-A94B-4B0A1C1FC063Q33646324-D373F62C-CA94-4DB7-A9BE-C3687D03E82AQ33886219-61D3FB5A-A3B1-4DCD-84C2-ABB57946B103Q35550696-00394189-47CF-49F6-9CA3-A5B785ACCF95Q35608422-89047C52-17A0-40FD-BF03-BB1E3F433DD2Q35788989-E755D05D-EC4C-4683-A5CB-EF23FDD4F647Q36309032-05FCBD4B-A852-471F-A29C-54684E07FF0AQ36725528-8E1E1BBB-E63A-4246-971C-79BE4A289569Q37045918-40113ECD-074D-484B-AB8B-8E9EC74F0B4BQ37113004-A61098D9-2A71-4CED-B912-1445BAE8EA7CQ37265117-50A80C77-F620-4337-A4CB-AD6E18F7E700Q37624954-4156D95C-6C9C-496E-A9CD-683D41FD5F5BQ37801828-43538B3D-3927-4131-9333-89CCBF04B0E2Q38184922-6509239F-8081-4D27-BD3D-07E3B3E05B6DQ38404587-0CA70298-D02C-43E1-B834-F54E11CD235DQ41861331-DED15095-A774-4DE7-94F2-AF20FC85D6D0Q42912165-BE87E83C-29B0-4A24-83F0-38B2F0F1EC35Q44063760-A6756BE4-849D-4A02-98F0-ED1618C8D29FQ51289036-EA286FBB-F30A-4764-AD97-C72BF8F5889BQ54236852-E0608696-D948-40AA-94D9-A40839E03B57Q54426389-FDA0D823-D980-4EB3-BA41-BA74201D1CD3Q56905945-21034CA6-4FF2-4478-82BE-CC9F28F01947
P2860
End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
End-stage renal disease in pat ...... data from the Fabry Registry.
@ast
End-stage renal disease in pat ...... data from the Fabry Registry.
@en
End-stage renal disease in pat ...... data from the Fabry Registry.
@nl
type
label
End-stage renal disease in pat ...... data from the Fabry Registry.
@ast
End-stage renal disease in pat ...... data from the Fabry Registry.
@en
End-stage renal disease in pat ...... data from the Fabry Registry.
@nl
prefLabel
End-stage renal disease in pat ...... data from the Fabry Registry.
@ast
End-stage renal disease in pat ...... data from the Fabry Registry.
@en
End-stage renal disease in pat ...... data from the Fabry Registry.
@nl
P2093
P50
P356
P1476
End-stage renal disease in pat ...... data from the Fabry Registry.
@en
P2093
Bojan Vujkovac
Bruno Cianciaruso
Christoph Wanner
David G Warnock
Jacobo Villalobos
Marta Cizmarik
Renzo Mignani
Stephen Waldek
P304
P356
10.1093/NDT/GFP554
P407
P577
2009-10-21T00:00:00Z